Joint statement by the European Centre for Disease Prevention and Control, European Chemicals Agency, European Environment Agency, European Food Safety Authority and European Medicines Agency.
Since the risk assessment published by ECDC in August 2021 on the risk of vCJD disease transmission via blood and PDMP manufactured from donations obtained in the UK, no new cases of vCJD associated with dietary exposure or transfusion of blood or blood components have been reported in EU/EEA or in the rest of the world.
The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
This document provides laboratories with a single protocol for producing recombinant full-length hamster prion protein and using it to perform the Real-Time Quaking-Induced Conversion assay (RT-QuIC), which can distinguish sporadic Creutzfeldt-Jakob disease (sCJD) from variant Creutzfeldt-Jakob disease (vCJD).
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
This document explains the operating procedures of the European Legionnaires’ Disease Surveillance Network, coordinated by ECDC. It specifically relates to reporting cases of travel-associated Legionnaires’ disease arising from stays in hotel or other commercial holiday accommodation. The aim is to quickly identify and control outbreaks of the disease and minimise the risk to holidaymakers. This edition supersedes the January 2012 edition.
This ECDC communication toolkit aims to support EU/EEA countries in their communication initiatives to increase immunisation uptake, in particular childhood vaccination. It provides template materials that health authorities can adapt to develop their own communication initiatives, in line with national, regional or local strategies and needs.
This publication aims to support the strengthening of antenatal screening programmes for HIV, hepatitis B, syphilis and rubella susceptibility in the general population and in groups identified as vulnerable to mother-to-child-transmission in the EU/EEA.
This publication aims to provide EU/EEA data providers with a single protocol for performing multiple-locus variable-number tandem repeat analysis (MLVA) of Salmonella enterica serotype Enteritidis (S. Enteritidis) and thereby ensure interlaboratory comparability of the generated results using capillary electrophoresis (CE).
This document provides a checklist of infectious diseases to be considered among migrant populations and serves as a reminder for frontline healthcare workers of the risks of infectious diseases for newly-arrived migrants.